Found 7 hits of ki for monomerid = 50319627 Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
Aurora kinase A
(Homo sapiens (Human)) | BDBM50319627
(1-(4-(4-(4-(2,4-Dimethylthiazol-5-yl)pyrimidin-2-y...)Show SMILES CC(=O)N1CCN(CC1)c1ccc(Nc2nccc(n2)-c2sc(C)nc2C)cc1 Show InChI InChI=1S/C21H24N6OS/c1-14-20(29-15(2)23-14)19-8-9-22-21(25-19)24-17-4-6-18(7-5-17)27-12-10-26(11-13-27)16(3)28/h4-9H,10-13H2,1-3H3,(H,22,24,25) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| 8.20 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cyclacel Ltd.
Curated by ChEMBL
| Assay Description Inhibition of human recombinant Aurora A after 30 mins |
J Med Chem 53: 4367-78 (2010)
Article DOI: 10.1021/jm901913s BindingDB Entry DOI: 10.7270/Q2930T9D |
More data for this Ligand-Target Pair | |
Aurora kinase B
(Homo sapiens (Human)) | BDBM50319627
(1-(4-(4-(4-(2,4-Dimethylthiazol-5-yl)pyrimidin-2-y...)Show SMILES CC(=O)N1CCN(CC1)c1ccc(Nc2nccc(n2)-c2sc(C)nc2C)cc1 Show InChI InChI=1S/C21H24N6OS/c1-14-20(29-15(2)23-14)19-8-9-22-21(25-19)24-17-4-6-18(7-5-17)27-12-10-26(11-13-27)16(3)28/h4-9H,10-13H2,1-3H3,(H,22,24,25) | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| 13 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cyclacel Ltd.
Curated by ChEMBL
| Assay Description Inhibition of human recombinant Aurora B after 60 mins |
J Med Chem 53: 4367-78 (2010)
Article DOI: 10.1021/jm901913s BindingDB Entry DOI: 10.7270/Q2930T9D |
More data for this Ligand-Target Pair | |
Cyclin-dependent kinase 2
(Homo sapiens (Human)) | BDBM50319627
(1-(4-(4-(4-(2,4-Dimethylthiazol-5-yl)pyrimidin-2-y...)Show SMILES CC(=O)N1CCN(CC1)c1ccc(Nc2nccc(n2)-c2sc(C)nc2C)cc1 Show InChI InChI=1S/C21H24N6OS/c1-14-20(29-15(2)23-14)19-8-9-22-21(25-19)24-17-4-6-18(7-5-17)27-12-10-26(11-13-27)16(3)28/h4-9H,10-13H2,1-3H3,(H,22,24,25) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| 432 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cyclacel Ltd.
Curated by ChEMBL
| Assay Description Inhibition of CDK2 |
J Med Chem 53: 4367-78 (2010)
Article DOI: 10.1021/jm901913s BindingDB Entry DOI: 10.7270/Q2930T9D |
More data for this Ligand-Target Pair | |
Cyclin-dependent kinase 4
(Homo sapiens (Human)) | BDBM50319627
(1-(4-(4-(4-(2,4-Dimethylthiazol-5-yl)pyrimidin-2-y...)Show SMILES CC(=O)N1CCN(CC1)c1ccc(Nc2nccc(n2)-c2sc(C)nc2C)cc1 Show InChI InChI=1S/C21H24N6OS/c1-14-20(29-15(2)23-14)19-8-9-22-21(25-19)24-17-4-6-18(7-5-17)27-12-10-26(11-13-27)16(3)28/h4-9H,10-13H2,1-3H3,(H,22,24,25) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| 929 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cyclacel Ltd.
Curated by ChEMBL
| Assay Description Inhibition of CDK4 |
J Med Chem 53: 4367-78 (2010)
Article DOI: 10.1021/jm901913s BindingDB Entry DOI: 10.7270/Q2930T9D |
More data for this Ligand-Target Pair | |
Cyclin-dependent kinase 9
(Homo sapiens (Human)) | BDBM50319627
(1-(4-(4-(4-(2,4-Dimethylthiazol-5-yl)pyrimidin-2-y...)Show SMILES CC(=O)N1CCN(CC1)c1ccc(Nc2nccc(n2)-c2sc(C)nc2C)cc1 Show InChI InChI=1S/C21H24N6OS/c1-14-20(29-15(2)23-14)19-8-9-22-21(25-19)24-17-4-6-18(7-5-17)27-12-10-26(11-13-27)16(3)28/h4-9H,10-13H2,1-3H3,(H,22,24,25) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| 1.15E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cyclacel Ltd.
Curated by ChEMBL
| Assay Description Inhibition of CDK9 |
J Med Chem 53: 4367-78 (2010)
Article DOI: 10.1021/jm901913s BindingDB Entry DOI: 10.7270/Q2930T9D |
More data for this Ligand-Target Pair | |
Cyclin-dependent kinase 1
(Homo sapiens (Human)) | BDBM50319627
(1-(4-(4-(4-(2,4-Dimethylthiazol-5-yl)pyrimidin-2-y...)Show SMILES CC(=O)N1CCN(CC1)c1ccc(Nc2nccc(n2)-c2sc(C)nc2C)cc1 Show InChI InChI=1S/C21H24N6OS/c1-14-20(29-15(2)23-14)19-8-9-22-21(25-19)24-17-4-6-18(7-5-17)27-12-10-26(11-13-27)16(3)28/h4-9H,10-13H2,1-3H3,(H,22,24,25) | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| 1.89E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cyclacel Ltd.
Curated by ChEMBL
| Assay Description Inhibition of CDK1 |
J Med Chem 53: 4367-78 (2010)
Article DOI: 10.1021/jm901913s BindingDB Entry DOI: 10.7270/Q2930T9D |
More data for this Ligand-Target Pair | |
Cyclin-dependent kinase 7
(Homo sapiens (Human)) | BDBM50319627
(1-(4-(4-(4-(2,4-Dimethylthiazol-5-yl)pyrimidin-2-y...)Show SMILES CC(=O)N1CCN(CC1)c1ccc(Nc2nccc(n2)-c2sc(C)nc2C)cc1 Show InChI InChI=1S/C21H24N6OS/c1-14-20(29-15(2)23-14)19-8-9-22-21(25-19)24-17-4-6-18(7-5-17)27-12-10-26(11-13-27)16(3)28/h4-9H,10-13H2,1-3H3,(H,22,24,25) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| 2.80E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cyclacel Ltd.
Curated by ChEMBL
| Assay Description Inhibition of CDK7 |
J Med Chem 53: 4367-78 (2010)
Article DOI: 10.1021/jm901913s BindingDB Entry DOI: 10.7270/Q2930T9D |
More data for this Ligand-Target Pair | |